Strides Pharma Science (NSE:STAR) Effective Interest Rate on Debt % : 9.04% (As of Dec. 2024)

View and export this data going back to 2000. Start your Free Trial

What is Strides Pharma Science Effective Interest Rate on Debt %?

Effective Interest Rate on Debt % is the usage rate that a borrower actually pays on a debt. It is calculated as the positive value of Interest Expense divided by its average total debt. Total debt equals to Long-Term Debt & Capital Lease Obligation plus Short-Term Debt & Capital Lease Obligation. Strides Pharma Science's annualized positive value of Interest Expense for the quarter that ended in Dec. 2024 was ₹2,087 Mil. Strides Pharma Science's average total debt for the quarter that ended in Dec. 2024 was ₹23,085 Mil. Therefore, Strides Pharma Science's annualized Effective Interest Rate on Debt % for the quarter that ended in Dec. 2024 was 9.04%.

Strides Pharma Science Effective Interest Rate on Debt % Historical Data

The historical data trend for Strides Pharma Science's Effective Interest Rate on Debt % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Strides Pharma Science Effective Interest Rate on Debt % Chart

Strides Pharma Science Annual Data

Trend

Mar15

Mar16

Mar17

Mar18

Mar19

Mar20

Mar21

Mar22

Mar23

Mar24

Effective Interest Rate on Debt %

Get a 7-Day Free Trial

1.11

5.81

5.42

7.19

9.83

Strides Pharma Science Quarterly Data
	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24
Effective Interest Rate on Debt %	Get a 7-Day Free Trial															9.98	10.11	12.78	14.23	9.04

Competitive Comparison of Strides Pharma Science's Effective Interest Rate on Debt %

For the Drug Manufacturers - Specialty & Generic subindustry, Strides Pharma Science's Effective Interest Rate on Debt %, along with its competitors' market caps and Effective Interest Rate on Debt % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Strides Pharma Science's Effective Interest Rate on Debt % Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Strides Pharma Science's Effective Interest Rate on Debt % distribution charts can be found below:

* The bar in red indicates where Strides Pharma Science's Effective Interest Rate on Debt % falls into.

Save Embed

;

Save Embed

;

Strides Pharma Science Effective Interest Rate on Debt % Calculation

Strides Pharma Science's annualized Effective Interest Rate on Debt % for the fiscal year that ended in Mar. 2024 is calculated as

	Effective Interest Rate on Debt %
=	-1 * Interest Expense	/	( (Total Debt (A: Mar. 2023 )	+	Total Debt (A: Mar. 2024 ))	/ count )
=	-1 * -2727.29	/	( (30295.72	+	25168.65)	/ 2 )
=	-1 * -2727.29	/	27732.185
=	9.83 %

where

	Total Debt (A: Mar. 2023 )
=	Long-Term Debt & Capital Lease Obligation	+	Short-Term Debt & Capital Lease Obligation
=	13434.66	+	16861.06
=	30295.72

	Total Debt (A: Mar. 2024 )
=	Long-Term Debt & Capital Lease Obligation	+	Short-Term Debt & Capital Lease Obligation
=	7431.34	+	17737.31
=	25168.65

Strides Pharma Science's annualized Effective Interest Rate on Debt % for the quarter that ended in Dec. 2024 is calculated as

	Effective Interest Rate on Debt %
=	-1 * Interest Expense	/	( (Total Debt (Q: Sep. 2024 )	+	Total Debt (Q: Dec. 2024 ))	/ count )
=	-1 * -2087.28	/	( (23084.92	+	0)	/ 1 )
=	-1 * -2087.28	/	23084.92
=	9.04 %

where

	Total Debt (Q: Sep. 2024 )
=	Long-Term Debt & Capital Lease Obligation	+	Short-Term Debt & Capital Lease Obligation
=	6394.99	+	16689.93
=	23084.92

	Total Debt (Q: Dec. 2024 )
=	Long-Term Debt & Capital Lease Obligation	+	Short-Term Debt & Capital Lease Obligation
=	0	+	0
=	0

In the calculation of annual Effective Interest Rate on Debt %, the Interest Expense of the last fiscal year and the average total debt over the fiscal year are used. In calculating the quarterly data, the Interest Expense data used here is four times the quarterly (Dec. 2024) interest expense data. Effective Interest Rate on Debt % is displayed in the 30-year financial page.

Strides Pharma Science (NSE:STAR) Effective Interest Rate on Debt % Explanation

Effective Interest Rate on Debt % measures the usage rate that a borrower actually pays on a debt.

Strides Pharma Science Effective Interest Rate on Debt % Related Terms

Thank you for viewing the detailed overview of Strides Pharma Science's Effective Interest Rate on Debt % provided by GuruFocus.com. Please click on the following links to see related term pages.

Strides Pharma Science Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Strides Pharma Science Ltd (NSE:STAR) » Definitions » Effective Interest Rate on Debt %

Traded in Other Exchanges

532531:India

Address

Strides House, Bannerghatta Road, Bilekahalli, Bengaluru, KA, IND, 560 076

Website

https://www.strides.com

Strides Pharma Science Ltd is a specialty and generic drug manufacturer. The company focuses on developing niche and complex pharmaceutical products across therapeutic segments for regulated and emerging markets. Strides' emerging-market plan focuses on branded generics for the treatment of chronic therapies. The company considers merger and acquisition investment as a potential component of its operational growth plan for expanding its research, development, manufacturing, and marketing capabilities. The company's reportable segment are; Pharmaceutical & Bio-pharmaceutical.

Strides Pharma Science Headlines

No Headlines